<DOC>
	<DOCNO>NCT00342628</DOCNO>
	<brief_summary>The purpose study evaluate safety , immunogenicity , compatibility Vi-rEPA conjugate administer infant routine vaccination . We propose recruit 300 full term healthy newborn Vietnam randomly divide receive Vi-rEPA plus DTP , Hib-TT ( yet use Vietnam ) plus DTP , DTP alone . Consent obtain follow interview mother prenatal visit , delivery . All vaccine administer 2 , 4 , 6 month . A booster Vi-rEPA Hib-TT conjugate administer 12 month age reaction monitor 6 , 24 48 hour injection . Maternal cord blood sample collect labor delivery . Blood take 7 , 12 month age study infant 13 month infant inject Vi-rEPA Hib-TT 12 month . The blood sample assay Vi , Hib , diphtheria , tetanus pertussis antibody . The level serum IgG anti-Vi elicit Vi-rEPA administer infant schedule compare elicit vaccine 2 5 year-olds efficacy trial conduct Dong Thap Province , Vietnam .</brief_summary>
	<brief_title>Safety , Immunogenicity Compatibility With DTP Typhoid Fever Vaccine Infants</brief_title>
	<detailed_description>Typhoid fever remain common , serious , difficult-to-treat throughout world include Vietnam . Limitations three license typhoid vaccine prevent use routine vaccination infant . The recent , Vi polysaccharide typhoid vaccine useful individual great equal 5 year age age-related T-cell independent property . The immunogenicity Vi individual less 5 years-old improve binding protein . In 2 4-year-olds , 2 injection Vi conjugate induce high level serum IgG anti-Vi Vi 5 14-year-olds . A double-blind , placebo control randomize efficacy study 2 -to-5 year old child Vietnam show over-all efficacy 27 month active surveillance follow 19 month passive surveillance 89 % . Subsequently dosage study age group show high antibody level induce 25 mcg dose . Now wish evaluate safety , immunogenicity , compatibility Vi-rEPA conjugate administer infant routine vaccination . We propose recruit 300 full term healthy newborn Vietnam randomly divide receive Vi-rEPA plus DTP ( Group A ) , Hib-TT ( yet use Vietnam ) plus DTP ( Group B ) , DTP alone ( Group C ) . Maternal cord blood take routinely deliveries Vietnam ; serum retrieve storage consent obtain follow interview mother prenatal visit , delivery . All vaccine administer 2 , 4 , 6 month . A booster Vi-rEPA Hib-TT conjugate administer 12 month age reaction monitor 6 , 24 48 hour injection . Blood take 7 , 12 month age study infant 13 month infant inject Vi-rEPA Hib-TT 12 month . The blood sample assay Vi , Hib , diphtheria , tetanus pertussis antibody . The level serum IgG anti-Vi elicit Vi-rEPA administer infant schedule compare elicit vaccine 2 5 year-olds efficacy trial conduct Dong Thap .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Typhoid Fever</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : Healthy fullterm newborn . Birth weight &gt; =2500 gram . Exclusion criterion : Newborns without maternal cord blood sample Newborns bear mother serious medical problem .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Antibody</keyword>
	<keyword>Reactions</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Conjugate Vaccine</keyword>
	<keyword>Typhoid Fever</keyword>
	<keyword>Trial</keyword>
	<keyword>Safety</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Comparability</keyword>
	<keyword>DTP</keyword>
</DOC>